- Home
- DNLI vs FHB Comparison
DNLI vs FHB Comparison
Compare DNLI & FHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DNLI | FHB |
|---|---|---|
| Founded | 2013 | 1858 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 2017 | 2016 |
Fundamental Metrics
Financial Performance| Metric | DNLI | FHB |
|---|---|---|
| Price | $23.11 | $28.35 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 14 | 7 |
| Target Price | ★ $34.33 | $27.00 |
| AVG Volume (30 Days) | 1.9M | ★ 2.6M |
| Earning Date | 05-06-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 3.86% |
| EPS Growth | N/A | ★ 22.91 |
| EPS | N/A | ★ 0.55 |
| Revenue | N/A | ★ $880,788,000.00 |
| Revenue This Year | N/A | $7.00 |
| Revenue Next Year | $408.85 | $3.56 |
| P/E Ratio | ★ N/A | $52.09 |
| Revenue Growth | N/A | ★ 8.94 |
| 52 Week Low | $12.58 | $22.65 |
| 52 Week High | $27.30 | $30.58 |
Technical Indicators
Market Signals| Indicator | DNLI | FHB |
|---|---|---|
| Relative Strength Index (RSI) | 45.21 | 45.38 |
| Support Level | $18.27 | $26.12 |
| Resistance Level | $23.27 | $28.69 |
| Average True Range (ATR) | 1.38 | 0.68 |
| MACD | -0.39 | -0.20 |
| Stochastic Oscillator | 17.58 | 35.09 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About FHB First Hawaiian Inc.
First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.